Neurotoxicity of nanoscale materials

Journal of Food and Drug Analysis

Volumn 22, Issue 1, 2014, Pages 147-160

  Karmakar, Alokita ^a   Zhang, Qinli ^b   Zhang, Yongbin ^a  

^a NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

^b SHANXI MEDICAL UNIVERSITY   (China)

Author keywords

Blood brain barrier; Nanomaterial; Neurotoxicity; Oxidative stress

Indexed keywords

ALUMINUM OXIDE NANOPARTICLE; CARBON; COPPER NANOPARTICLE; COPPER OXIDE NANOPARTICLE; DOUBLE WALLED NANOTUBE; FULLERENE DERIVATIVE; MANGANESE OXIDE NANOPARTICLE; METAL; METAL OXIDE; MULTI WALLED NANOTUBE; NANOMATERIAL; NANOPARTICLE; SILICON DIOXIDE NANOPARTICLE; SILVER NANOPARTICLE; SINGLE WALLED NANOTUBE; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; TITANIUM DIOXIDE NANOPARTICLE; UNCLASSIFIED DRUG; ZINC OXIDE NANOPARTICLE;

BLOOD BRAIN BARRIER; COMBUSTION; EXPOSURE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; NANOTECHNOLOGY; NANOTOXICOLOGY; NERVOUS SYSTEM; NEUROTOXICITY; NONHUMAN; OLFACTORY BULB; OXIDATIVE STRESS; REVIEW; ANIMAL; CHEMISTRY; TOXICITY; TOXICOLOGY;

ANIMALS; HUMANS; NANOSTRUCTURES; NERVOUS SYSTEM; OXIDATIVE STRESS; TOXICOLOGY;

EID: 84901594129     PISSN: 10219498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jfda.2014.01.012     Document Type: Review

References (156)

1. Sharma HS. A special section on nanoneuroscience: nanoneurotoxicity and nanoneuroprotection. J Nanosci Nanotechnol 2009;9:4992-5.
2. Song Y, Tang S. Nanoexposure, unusual diseases, and new health and safety concerns. ScientificWorldJournal 2011;11:1821-8.
3. Zhang R, Bai Y, Zhang B, et al. The potential health risk of titania nanoparticles. J Hazard Mater 2012;211-212:404-13.
4. Kulvietis V, Zalgeviciene V, Didziapetriene J, et al. Transport of nanoparticles through the placental barrier. Tohoku J Exp Med 2011;225:225-34.
5. Jachak A, Lai SK, Hida K, et al. Transport of metal oxide nanoparticles and single-walled carbon nanotubes in human mucus. Nanotoxicology 2012;6:614-22.
6. Konczol M, Ebeling S, Goldenberg E, et al. Cytotoxicity and genotoxicity of size-fractionated iron oxide (magnetite) in A549 human lung epithelial cells: role of ROS, JNK, and NF-kappaB. Chem Res Toxicol 2011;24:1460-75.
7. Peters A, Ruckerl R, Cyrys J. Lessons from air pollution epidemiology for studies of engineered nanomaterials. J Occup Environ Med 2011;53:S8-13.
8. Eisen EA, Costello S, Chevrier J, et al. Epidemiologic challenges for studies of occupational exposure to engineered nanoparticles; a commentary. J Occup Environ Med 2011;53:S57-61.
9. Heng BC, Zhao X, Tan EC, et al. Evaluation of the cytotoxic and inflammatory potential of differentially shaped zinc oxide nanoparticles. Arch Toxicol 2011;85:1517-28.
10. Sharma HS, Muresanu DF, Patnaik R, et al. Superior neuroprotective effects of cerebrolysin in heat stroke following chronic intoxication of Cu or Ag engineered nanoparticles. A comparative study with other neuroprotective agents using biochemical and morphological approaches in the rat. J Nanosci Nanotechnol 2011;11:7549-69.
11. Lanone S, Boczkowski J. Biomedical applications and potential health risks of nanomaterials: molecular mechanisms. Curr Mol Med 2006;6:651-63.
12. Kreuter J, Alyautdin RN, Kharkevich DA, et al. Passage of peptides through the blood-brain barrier with colloidal polymer particles (nanoparticles). Brain Res 1995;674:171-4.
13. Sharma HS, Ali SF, Hussain SM, et al. Influence of engineered nanoparticles from metals on the blood-brain barrier permeability, cerebral blood flow, brain edema and neurotoxicity. An experimental study in the rat and mice using biochemical and morphological approaches. J Nanosci Nanotechnol 2009;9:5055-72.
14. Ahmed J, Gubrud M. Anticipating military nanotechnology. Technol Soc Magazine IEEE 2004;23:33-40.
15. Burch WM. Passage of inhaled particles into the blood circulation in humans. Circulation 2002;106:e141-2.
16. Takenaka S, Karg E, Roth C, et al. Pulmonary and systemic distribution of inhaled ultrafine silver particles in rats. Environ Health Perspect 2001;109(Suppl 4):547-51.
17. Oberdorster G, Sharp Z, Atudorei V, et al. Translocation of inhaled ultrafine particles to the brain. Inhal Toxicol 2004;16:437-45.
18. De Lorenzo AJD. The olfactory neuron and the blood-brain barrier. In: Ciba Foundation symposium-internal secretions of the pancreas (colloquia on endocrinology). John Wiley & Sons; 2008. pp. 151-76.
19. Tjalve H, Henriksson J, Tallkvist J, et al. Uptake of manganese and cadmium from the nasal mucosa into the central nervous system via olfactory pathways in rats. Pharmacol Toxicol 1996;79:347-56.
20. Tallkvist J, Henriksson J, d'Argy R, et al. Transport and subcellular distribution of nickel in the olfactory system of pikes and rats. Toxicol Sci 1998;43:196-203.
21. Tjalve H, Henriksson J. Uptake of metals in the brain via olfactory pathways. Neurotoxicology 1999;20:181-95.
22. Henriksson J, Tjalve H. Manganese taken up into the CNS via the olfactory pathway in rats affects astrocytes. Toxicol Sci 2000;55:392-8.
23. Persson E, Henriksson J, Tjalve H. Uptake of cobalt from the nasal mucosa into the brain via olfactory pathways in rats. Toxicol Lett 2003;145:19-27.
24. Elder A, Gelein R, Silva V, et al. Translocation of inhaled ultrafine manganese oxide particles to the central nervous system. Environ Health Perspect 2006;114:1172-8.
25. Zhang Y, Chen W, Zhang J, et al. In vitro and in vivo toxicity of CdTe nanoparticles. J Nanosci Nanotechnol 2007;7:497-503.
26. Popovsky M. Nanotechnology and environmental insurance. Columbia J Environ Law 2011;36:125.
27. Brunner TJ, Wick P, Manser P, et al. In vitro cytotoxicity of oxide nanoparticles: comparison to asbestos, silica, and the effect of particle solubility. Environ Sci Technol 2006;40:4374-81.
28. Sager TM, Kommineni C, Castranova V. Pulmonary response to intratracheal instillation of ultrafine versus fine titanium dioxide: role of particle surface area. Part Fibre Toxicol 2008;5:17.
29. ILSI Risk Science Institute. The relevance of the rat lung response to particle overload for human risk assessment: a workshop consensus report. Inhal Toxicol 2000;12:1-17.
30. National Institute for Occupational Safety and Health. NIOSH pocket guide to chemical hazards and other databases. Publication No. 2002-140. Cincinnati: US Department of Health and Human Services, Public Health Service, Centers for Disease Control, National Institute of Occupational Safety and Health, DHHS (NIOSH); 2002.
31. National Institute for Occupational Safety and Health. Occupational exposure to titanium dioxide. Publication No. 2011-160 Cincinnati. US Department of Health and Human Services, Public Health Service, Centers for Disease Control, National Institute of Occupational Safety and Health, DHHS (NIOSH); 2011.
32. World Health Organization. Titanium dioxide. EHC 24. Geneva: WHO; 1982.
33. Nordberg GF, Fowler BA, Nordberg M, et al. Titanium. In: Handbook of the toxicology of metals. 3rd ed. Amsterdam: Elsevier; 2007.
34. Rahman Q, Lohani M, Dopp E, et al. Evidence that ultrafine titanium dioxide induces micronuclei and apoptosis in Syrian hamster embryo fibroblasts. Environ Health Perspect 2002;110:797-800.
35. Hedenborg M. Titanium dioxide induced chemiluminescence of human polymorphonuclear leukocytes. Int Arch Occup Environ Health 1988;61:1-6.
36. Duan Y, Liu J, Ma L, et al. Toxicological characteristics of nanoparticulate anatase titanium dioxide in mice. Biomaterials 2010;31:894-9.
37. Chen J, Dong X, Zhao J, et al. In vivo acute toxicity of titanium dioxide nanoparticles to mice after intraperitioneal injection. J Appl Toxicol 2009;29:330-7.
38. Liang G, Pu Y, Yin L, et al. Influence of different sizes of titanium dioxide nanoparticles on hepatic and renal functions in rats with correlation to oxidative stress. J Toxicol Environ Health A 2009;72:740-5.
39. Wang J, Chen C, Liu Y, et al. Potential neurological lesion after nasal instillation of TiO2 nanoparticles in the anatase and rutile crystal phases. Toxicol Lett 2008;183:72-80.
40. Nel A, Xia T, Madler L, et al. Toxic potential of materials at the nanolevel. Science 2006;311:622-7.
41. Cho WS, Duffin R, Poland CA, et al. Metal oxide nanoparticles induce unique inflammatory footprints in the lung: important implications for nanoparticle testing. Environ Health Perspect 2010;118:1699-706.
42. Li Y, Li J, Yin J, et al. Systematic influence induced by 3 nm titanium dioxide following intratracheal instillation of mice. J Nanosci Nanotechnol 2010;10:8544-9.
43. Wang JX, Li YF, Zhou GQ, et al. Influence of intranasal instilled titanium dioxide nanoparticles on monoaminergic neurotransmitters of female mice at different exposure time. Zhonghua Yu Fang Yi Xue Za Zhi 2007;41:91-5 [in Chinese].
44. Wang J, Liu Y, Jiao F, et al. Time-dependent translocation and potential impairment on central nervous system by intranasally instilled TiO2 nanoparticles. Toxicology 2008;254:82-90.
45. Ma L, Liu J, Li N, et al. Oxidative stress in the brain of mice caused by translocated nanoparticulate TiO2 delivered to the abdominal cavity. Biomaterials 2010;31:99-105.
46. Hu R, Gong X, Duan Y, et al. Neurotoxicological effects and the impairment of spatial recognition memory in mice caused by exposure to TiO2 nanoparticles. Biomaterials 2010;31:8043-50.
47. Jeon YM, Park SK, Lee MY. Toxicoproteomic identification of TiO2 nanoparticle-induced protein expression changes in mouse brain. Animal Cells Syst 2011;15:107-14.
48. Long TC, Saleh N, Tilton RD, et al. Titanium dioxide (P25) produces reactive oxygen species in immortalized brain microglia (BV2): implications for nanoparticle neurotoxicity. Environ Sci Technol 2006;40:4346-52.
49. Long TC, Tajuba J, Sama P, et al. Nanosize titanium dioxide stimulates reactive oxygen species in brain microglia and damages neurons in vitro. Environ Health Perspect 2007;115:1631-7.
50. Liu S, Xu L, Zhang T, et al. Oxidative stress and apoptosis induced by nanosized titanium dioxide in PC12 cells. Toxicology 2010;267:172-7.
51. Shin JA, Lee EJ, Seo SM, et al. Nanosized titanium dioxide enhanced inflammatory responses in the septic brain of mouse. Neuroscience 2010;165:445-54.
52. Yamashita K, Yoshioka Y, Higashisaka K, et al. Silica and titanium dioxide nanoparticles cause pregnancy complications in mice. Nat Nanotechnol 2011;6:321-8.
53. Takeda K, Suzuki K, Ishihara A, et al. Nanoparticles transferred from pregnant mice to their offspring can damage the genital and cranial nerve systems. J Health Sci 2009;55:95-102.
54. Shimizu M, Tainaka H, Oba T, et al. Maternal exposure to nanoparticulate titanium dioxide during the prenatal period alters gene expression related to brain development in the mouse. Part Fibre Toxicol 2009;6:20.
55. Takahashi Y, Mizuo K, Shinkai Y, et al. Prenatal exposure to titanium dioxide nanoparticles increases dopamine levels in the prefrontal cortex and neostriatum of mice. J Toxicol Sci 2010;35:749-56.
56. Brayner R, Ferrari-Iliou R, Brivois N, et al. Toxicological impact studies based on Escherichia coli bacteria in ultrafine ZnO nanoparticles colloidal medium. Nano Lett 2006;6:866-70.
57. Roselli M, Finamore A, Garaguso I, et al. Zinc oxide protects cultured enterocytes from the damage induced by Escherichia coli. J Nutr 2003;133:4077-82.
58. Deng X, Luan Q, Chen W, et al. Nanosized zinc oxide particles induce neural stem cell apoptosis. Nanotechnology 2009;20:115101.
59. Zhao J, Xu L, Zhang T, et al. Influences of nanoparticle zinc oxide on acutely isolated rat hippocampal CA3 pyramidal neurons. Neurotoxicology 2009;30:220-30.
60. Han D, Tian Y, Zhang T, et al. Nano-zinc oxide damages spatial cognition capability via over-enhanced long-term potentiation in hippocampus of Wistar rats. Int J Nanomed 2011;6:1453-61.
61. Darroudi M, Sabouri Z, Oskuee RK, et al. Neuronal toxicity of biopolymer-template synthesized ZnO nanoparticles. Nanomed J 2014;1:88-93.
62. Yamamoto O, Komatsu M, Sawai J, et al. Effect of lattice constant of zinc oxide on antibacterial characteristics. J Mater Sci Mater Med 2004;15:847-51.
63. Ghule K, Ghule AV, Chen B-J, et al. Preparation and characterization of ZnO nanoparticles coated paper and its antibacterial activity study. Green Chem 2006;8:1034-41.
64. Tam K, Djurišić A, Chan C, et al. Antibacterial activity of ZnO nanorods prepared by a hydrothermal method. Thin Solid Films 2008;516:6167-74.
65. Zhang L, Jiang Y, Ding Y, et al. Investigation into the antibacterial behaviour of suspensions of ZnO nanoparticles (ZnO nanofluids). J Nanopart Res 2007;9:479-89.
66. Reddy KM, Feris K, Bell J, et al. Selective toxicity of zinc oxide nanoparticles to prokaryotic and eukaryotic systems. Appl Phys Lett 2007;90:2139021-3.
67. Heinlaan M, Ivask A, Blinova I, et al. Toxicity of nanosized and bulk ZnO, CuO and TiO2 to bacteria Vibrio fischeri and crustaceans Daphnia magna and Thamnocephalus platyurus. Chemosphere 2008;71:1308-16.
68. Franklin NM, Rogers NJ, Apte SC, et al. Comparative toxicity of nanoparticulate ZnO, bulk ZnO, and ZnCl2 to a freshwater microalga (Pseudokirchneriella subcapitata): the importance of particle solubility. Environ Sci Technol 2007;41:8484-90.
69. Zhu X, Zhu L, Duan Z, et al. Comparative toxicity of several metal oxide nanoparticle aqueous suspensions to zebrafish (Danio rerio) early developmental stage. J Environ Sci Health A Tox Hazard Subst Environ Eng 2008;43:278-84.
70. Wang J, Wang B, Wang T-C, et al. Acute toxicological impact of nano-and submicro-scaled zinc oxide powder on healthy adult mice. J Nanopart Res 2008;10:263-76.
71. Finley JW, Davis CD. Manganese deficiency and toxicity: are high or low dietary amounts of manganese cause for concern? Biofactors 1999;10:15-24.
72. Hazardous Substances Data Bank. Manganese compounds. National Library of Medicine; 2006. http://toxnet.nlm.nih. gov/cgi-bin/sis/search/r?dbs+hsdb: @term+@rn+@rel+7439-96-5.
73. National Institute for Occupational Safety and Health. NIOSH pocket guide to chemical hazards. Publication No. 2005-149. Department of Health and Human Services, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health; 2007.
74. US Centers for Disease Control (ATSDR). Toxicological profile for manganese; 2000. http://www.atsdr.cdc.gov/toxprofiles/tp.asp?id=102&tid=23 [accessed 03.03.11].
75. Dobson AW, Erikson KM, Aschner M. Manganese neurotoxicity. Ann N Y Acad Sci 2004;1012:115-28.
76. Fechter LD, Johnson DL, Lynch R. The relationship of particle size to olfactory nerve uptake of a non-soluble form of manganese into brain. Neurotoxicology 2002;23:177-83.
77. Brenneman KA,Wong BA, Buccellato MA, et al. Direct olfactory transport of inhaledmanganese ((54)MnCl(2)) to the rat brain: toxicokinetic investigations in a unilateral nasal occlusion model. Toxicol Appl Pharmacol 2000;169:238-48.
78. Rao DB, Wong BA, McManus BE, et al. Inhaled iron, unlike manganese, is not transported to the rat brain via the olfactory pathway. Toxicol Appl Pharmacol 2003;193:116-26.
79. Dorman DC, Struve MF, James RA, et al. Influence of particle solubility on the delivery of inhaled manganese to the rat brain: manganese sulfate and manganese tetroxide pharmacokinetics following repeated (14-day) exposure. Toxicol Appl Pharmacol 2001;170:79-87.
80. Vitarella D, Wong BA, Moss OR, et al. Pharmacokinetics of inhaled manganese phosphate in male Sprague-Dawley rats following subacute (14-day) exposure. Toxicol Appl Pharmacol 2000;163:279-85.
81. Gulson B, Mizon K, Taylor A, et al. Changes in manganese and lead in the environment and young children associated with the introduction of methylcyclopentadienyl manganese tricarbonyl in gasoline e preliminary results. Environ Res 2006;100:100-14.
82. Cohen DD, Gulson BL, Davis JM, et al. Fine-particle Mn and other metals linked to the introduction of MMT into gasoline in Sydney, Australia: results of a natural experiment. Atmos Environ 2005;39:6885-96.
83. Stefanescu D, Khoshnan A, Patterson P, et al. Neurotoxicity of manganese oxide nanomaterials. J Nanopart Res 2009;11:1957-69.
84. Hussain SM, Javorina AK, Schrand AM, et al. The interaction of manganese nanoparticles with PC-12 cells induces dopamine depletion. Toxicol Sci 2006;92:456-63.
85. Oszlá nczi G, Vezér T, Sárközi L, et al. Functional neurotoxicity of Mn-containing nanoparticles in rats. Ecotoxicol Environ Saf 2010;73:2004-9.
86. Singh SP, Kumari M, Kumari SI, et al. Genotoxicity of nanoand micron-sized manganese oxide in rats after acute oral treatment. Mutat Res 2013;754:39-50.
87. Diana MS, Ali K, Paul HP, et al. Neurotoxicity of manganese oxide nanomaterials. J Nanopart Res 2009;11:1957-69.
88. Ahamed M, Alsalhi MS, Siddiqui MK. Silver nanoparticle applications and human health. Clin Chim Acta 2010;411:1841-8.
89. Lee HY, Park HK, Lee YM, et al. A practical procedure for producing silver nanocoated fabric and its antibacterial evaluation for biomedical applications. Chem Commun (Camb); 2007:2959-61.
90. Jain P, Pradeep T. Potential of silver nanoparticle-coated polyurethane foam as an antibacterial water filter. Biotechnol Bioeng 2005;90:59-63.
91. Zhang YY, Sun J. A study on the bio-safety for nano-silver as anti-bacterial materials. Zhongguo Yi Liao Qi Xie Za Zhi 2007;31:36-8. 16 [in Chinese].
92. Wijnhoven SWP, Peijnenburg WJGM, Herberts CA, et al. Nano-silver e a review of available data and knowledge gaps in human and environmental risk assessment. Nanotoxicology 2009;3:109-38.
93. Kim YS, Kim JS, Cho HS, et al. Twenty-eight-day oral toxicity, genotoxicity, and gender-related tissue distribution of silver nanoparticles in SpragueeDawley rats. Inhal Toxicol 2008;20:575-83.
94. Arora S, Jain J, Rajwade JM, et al. Cellular responses induced by silver nanoparticles: in vitro studies. Toxicol Lett 2008;179:93-100.
95. Arora S, Jain J, Rajwade JM, et al. Interactions of silver nanoparticles with primary mouse fibroblasts and liver cells. Toxicol Appl Pharmacol 2009;236:310-8.
96. Soto K, Garza KM, Murr LE. Cytotoxic effects of aggregated nanomaterials. Acta Biomater 2007;3:351-8.
97. Powers CM, Badireddy AR, Ryde IT, et al. Silver nanoparticles compromise neurodevelopment in PC12 cells: critical contributions of silver ion, particle size, coating, and composition. Environ Health Perspect 2011;119:37-44.
98. Tang J, Xiong L, Zhou G, et al. Silver nanoparticles crossing through and distribution in the blood-brain barrier in vitro. J Nanosci Nanotechnol 2010;10:6313-7.
99. Trickler WJ, Lantz SM, Murdock RC, et al. Silver nanoparticle induced blood-brain barrier inflammation and increased permeability in primary rat brain microvessel endothelial cells. Toxicol Sci 2010;118:160-70.
100. Tang J, Xiong L, Wang S, et al. Distribution, translocation and accumulation of silver nanoparticles in rats. J Nanosci Nanotechnol 2009;9:4924-32.
101. Liu Y, Guan W, Ren G, et al. The possible mechanism of silver nanoparticle impact on hippocampal synaptic plasticity and spatial cognition in rats. Toxicol Lett 2012;209:227-31.
102. Zhang Y, Ferguson SA, Watanabe F, et al. Silver nanoparticles decrease body weight and locomotor activity in adult male rats. Small 2013;9:1715-20.
103. Yin N, Liu Q, Liu J, et al. Silver nanoparticle exposure attenuates the viability of rat cerebellum granule cells through apoptosis coupled to oxidative stress. Small 2013;9:1831-41.
104. Hood E. Nanotechnology: looking as we leap. Environ Health Perspect 2004;112:A740-9.
105. Kong SD, Lee J, Ramachandran S, et al. Magnetic targeting of nanoparticles across the intact blood-brain barrier. J Control Release 2012;164:49-57.
106. Zhou R, Acton PD, Ferrari VA. Imaging stem cells implanted in infarcted myocardium. J Am Coll Cardiol 2006;48:2094-106.
107. Cromer Berman SM, Walczak P, Bulte JW. Tracking stem cells using magnetic nanoparticles. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2011;3:343-55.
108. Singh N, Jenkins GJ, Asadi R, et al. Potential toxicity of superparamagnetic iron oxide nanoparticles (SPION). Nano Rev 2010;1:5358. http://dx.doi.org/10.3402/nano.v1i0.5358.
109. Calderon-Garciduenas L, Reed W, Maronpot RR, et al. Brain inflammation and Alzheimer's-like pathology in individuals exposed to severe air pollution. Toxicol Pathol 2004;32:650-8.
110. Peters A, Veronesi B, Calderon-Garciduenas L, et al. Translocation and potential neurological effects of fine and ultrafine particles a critical update. Part Fibre Toxicol 2006;3:13.
111. Calderon-Garciduenas L, Solt AC, Henriquez-Roldan C, et al. Long-term air pollution exposure is associated with neuroinflammation, an altered innate immune response, disruption of the blood-brain barrier, ultrafine particulate deposition, and accumulation of amyloid beta-42 and alpha-synuclein in children and young adults. Toxicol Pathol 2008;36:289-310.
112. Lundqvist M, Stigler J, Cedervall T, et al. The evolution of the protein corona around nanoparticles: a test study. ACS Nano 2011;5:7503-9.
113. Mahmoudi M, Lynch I, Ejtehadi MR, et al. Proteinenanoparticle interactions: opportunities and challenges. Chem Rev 2011;111:5610-37.
114. Pisanic II TR, Blackwell JD, Shubayev VI, et al. Nanotoxicity of iron oxide nanoparticle internalization in growing neurons. Biomaterials 2007;28:2572-81.
115. Wang B, Feng W, Zhu M, et al. Neurotoxicity of low-dose repeatedly intranasal instillation of nano-and submicronsized ferric oxide particles in mice. J Nanopart Res 2009;11:41-53.
116. Wu J, Ding T, Sun J. Neurotoxic potential of iron oxide nanoparticles in the rat brain striatum and hippocampus. Neurotoxicology 2013;34:243-53.
117. Miller RM, Kiser GL, Kaysser-Kranich TM, et al. Robust dysregulation of gene expression in substantia nigra and striatum in Parkinson's disease. Neurobiol Dis 2006;21:305-13.
118. Coffey ET, Smiciene G, Hongisto V, et al. c-Jun N-terminal protein kinase (JNK) 2/3 is specifically activated by stress, mediating c-Jun activation, in the presence of constitutive JNK1 activity in cerebellar neurons. J Neurosci 2002;22:4335-45.
119. Wang B, Feng WY, Wang M, et al. Transport of intranasally instilled fine Fe2O3 particles into the brain: microdistribution, chemical states, and histopathological observation. Biol Trace Elem Res 2007;118:233-43.
120. Wang B, Wang Y, Feng W, et al. Trace metal disturbance in mice brain after intranasal exposure of nano-and submicron-sized Fe2O3 particles. Chem Anal 2008;53:927-42.
121. Kim NH, Park SJ, Jin JK, et al. Increased ferric iron content and iron-induced oxidative stress in the brains of scrapieinfected mice. Brain Res 2000;884:98-103.
122. Gaasch JA, Lockman PR, Geldenhuys WJ, et al. Brain iron toxicity: differential responses of astrocytes, neurons, and endothelial cells. Neurochem Res 2007;32:1196-208.
123. Castellani RJ, Moreira PI, Liu G, et al. Iron: the redox-active center of oxidative stress in Alzheimer disease. Neurochem Res 2007;32:1640-5.
124. Wang Y, Wang B, Zhu MT, et al. Microglial activation, recruitment and phagocytosis as linked phenomena in ferric oxide nanoparticle exposure. Toxicol Lett 2011;205:26-37.
125. Evans GW. Copper homeostasis in the mammalian system. Physiol Rev 1973;53:535-70.
126. Sternlieb I. Copper and the liver. Gastroenterology 1980;78:1615-28.
127. Nalbandyan RM. Copper in brain. Neurochem Res 1983;8:1211-32.
128. Halliwell B, Gutteridge JM. Role of free radicals and catalytic metal ions in human disease: an overview. Methods Enzymol 1990;186:1-85.
129. Galhardi CM, Diniz YS, Faine LA, et al. Toxicity of copper intake: lipid profile, oxidative stress and susceptibility to renal dysfunction. Food Chem Toxicol 2004;42:2053-60.
130. Aruoja V, Dubourguier HC, Kasemets K, et al. Toxicity of nanoparticles of CuO, ZnO and TiO2 to microalgae Pseudokirchneriella subcapitata. Sci Total Environ 2009;407:1461-8.
131. Sharma HS, Ali SF, Tian ZR, et al. Chronic treatment with nanoparticles exacerbate hyperthermia induced blood-brain barrier breakdown, cognitive dysfunction and brain pathology in the rat. Neuroprotective effects of nanowired-antioxidant compound H-290/51. J Nanosci Nanotechnol 2009;9:5073-90.
132. Li F, Zhou X, Zhu J, et al. High content image analysis for human H4 neuroglioma cells exposed to CuO nanoparticles. BMC Biotechnol 2007;7:66.
133. Prabhu BM, Ali SF, Murdock RC, et al. Copper nanoparticles exert size and concentration dependent toxicity on somatosensory neurons of rat. Nanotoxicology 2010;4:150-60.
134. Xu LJ, Zhao JX, Zhang T, et al. In vitro study on influence of nano particles of CuO on CA1 pyramidal neurons of rat hippocampus potassium currents. Environ Toxicol 2009;24:211-7.
135. Trickler WJ, Lantz SM, Schrand AM, et al. Effects of copper nanoparticles on rat cerebral microvessel endothelial cells. Nanomedicine (Lond) 2012;7:835-46.
136. Karlsson HL, Cronholm P, Gustafsson J, et al. Copper oxide nanoparticles are highly toxic: a comparison between metal oxide nanoparticles and carbon nanotubes. Chem Res Toxicol 2008;21:1726-32.
137. Liu Z, Liu S, Ren G, et al. Nano-CuO inhibited voltage-gated sodium current of hippocampal CA1 neurons via reactive oxygen species but independent from G-proteins pathway. J Appl Toxicol 2011;31:439-45.
138. Xiao AY, Wei L, Xia S, et al. Ionic mechanism of ouabain-induced concurrent apoptosis and necrosis in individual cultured cortical neurons. J Neurosci 2002;22:1350-62.
139. Janvier NC, McMorn SO, Harrison SM, et al. The role of Na+-Ca2+ exchange current in electrical restitution in ferret ventricular cells. J Physiol 1997;504:301-14.
140. Sitte HH, Farhan H, Javitch JA. Sodium-dependent neurotransmitter transporters: oligomerization as a determinant of transporter function and trafficking. Mol Interv 2004;4:38-47.
141. Armstrong CM. Sodium channels and gating currents. Physiol Rev 1981;61:644-83.
142. Yang N, George Jr AL, Horn R. Molecular basis of charge movement in voltage-gated sodium channels. Neuron 1996;16:113-22.
143. Chen J, Zhu J, Chob H-H, et al. Differential cytotoxicity of metal oxide nanoparticles. J Exptl Nanosci 2008;3:321-8.
144. Perreault F, Pedroso Melegari S, Henning da Costa C, et al. Genotoxic effects of copper oxide nanoparticles in Neuro 2A cell cultures. Sci Total Environ 2012;441:117-24.
145. Darlington TK, Neigh AM, Spencer MT, et al. Nanoparticle characteristics affecting environmental fate and transport through soil. Environ Toxicol Chem 2009;28:1191-9.
146. Zhang QL, Li MQ, Ji JW, et al. In vivo toxicity of nanoalumina on mice neurobehavioral profiles and the potential mechanisms. Int J Immunopathol Pharmacol 2011;24(1 Suppl.): 23S-9S.
147. Li Y, Yu S, Wu Q, et al. Chronic Al2O3-nanoparticle exposure causes neurotoxic effects on locomotion behaviors by inducing severe ROS production and disruption of ROS defense mechanisms in nematode Caenorhabditis elegans. J Hazard Mater; 2012:219-30.
148. Huang N, Yan Y, Xu Y, et al. Alumina nanoparticles alter rhythmic activities of local interneurons in the antennal lobe of Drosophila. Nanotoxicology 2013;7:212-20.
149. Chen L, Yokel RA, Hennig B, et al. Manufactured aluminum oxide nanoparticles decrease expression of tight junction proteins in brain vasculature. J Neuroimmune Pharmacol 2008;3:286-95.
150. Zhang Q, Xu L, Wang J, et al. Lysosomes involved in the cellular toxicity of nano-alumina: combined effects of particle size and chemical composition. J Biol Regul Homeost Agents 2013;27:365-75.
151. Li XB, Zheng H, Zhang ZR, et al. Glia activation induced by peripheral administration of aluminum oxide nanoparticles in rat brains. Nanomedicine 2009;5:473-9.
152. Wu J, Wang C, Sun J, et al. Neurotoxicity of silica nanoparticles: brain localization and dopaminergic neurons damage pathways. ACS Nano 2011;5:4476-89.
153. Kim Y-J, Yang SI. Neurotoxic effects by silica TM nanoparticle is independent of differentiation of SH-SY5Y cells. Mol Cell Toxicol 2011;7:381-8.
154. Zhang Y, Ali SF, Dervishi E, et al. Cytotoxicity effects of graphene and single-wall carbon nanotubes in neural phaeochromocytoma-derived PC12 cells. ACS Nano 2010;4:3181-6.
155. Zhang Y, Xu Y, Li Z, et al. Mechanistic toxicity evaluation of uncoated and PEGylated single-walled carbon nanotubes in neuronal PC12 cells. ACS Nano 2011;5:7020-33.
156. Tin-Tin-Win-Shwe, Yamamoto S, Ahmed S, et al. Brain cytokine and chemokine mRNA expression in mice induced by intranasal instillation with ultrafine carbon black. Toxicol Lett 2006;163:153-60.